Antitumor activity of a novel natural therapeutic agent against triple negative breast cancer

被引：1
|
作者：
Arora, Ritu [1 ]
Gary, Bernard D. [1 ]
McClellan, Steven [1 ]
Xi, Yaguang [1 ]
Piazza, Gary [1 ]
Reed, Eddie [1 ]
Owen, Laurie [1 ]
Dean-Colomb, Windy [1 ]
机构：
[1] Univ S Alabama, Mitchell Canc Inst, Mobile, AL 36688 USA
来源：
CANCER RESEARCH | 2013年 / 73卷 / 08期
关键词：
D O I：
10.1158/1538-7445.AM2013-5571
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5571
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Enhanced antitumor activity of lapatinib against triple-negative breast cancer via loading in human serum albumin
    Rostaminasab, Sadegh
    Esmaeili, Alireza
    Moosavi-Movahedi, Faezeh
    Memarkashani, Sahar
    Rudmianeh, Havva Rezaei
    Shourian, Mostafa
    Ardestani, Mehdi Shafiee
    Moosavi-Movahedi, Ali Akbar
    Asghari, S. Mohsen
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2024, 282
  • [32] Tamm-Horsfall protein as a novel antitumor therapy for triple negative breast cancer
    Mercogliano, Maria Florencia
    Bruni, Sofia
    De Martino, Mara
    Cavanagh, Elena
    Balanian, Liliana
    Sojo, Emilio
    Inserra, Felipe
    Groisman, Jose
    Schillaci, Roxana
    CANCER RESEARCH, 2022, 82 (12)
  • [33] Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells
    Tanei, Tomonori
    Choi, Dong Soon
    Rodriguez, Angel A.
    Liang, Diana Hwang
    Dobrolecki, Lacey
    Ghosh, Madhumita
    Landis, Melissa D.
    Chang, Jenny C.
    BREAST CANCER RESEARCH, 2016, 18
  • [34] Discovery of metformin derivatives with potent antitumor activity in triple-negative breast cancer
    Marquez-Garban, D. C.
    Deng, G.
    Anderson, N.
    Aivazyan, L.
    Kazmi, N.
    Hamilton, N.
    Jung, M. E.
    Pietras, R. J.
    CANCER RESEARCH, 2012, 72
  • [35] Antitumor activity of celecoxib with docetaxel on human triple-negative breast cancer cells
    Ajikanari, Oktay
    Miaadi, Elham
    Hedayat, Mohaddeseh
    Jafari, Reza
    Asghari, Rahim
    Zolbanin, Naime Majidi
    GENE REPORTS, 2025, 38
  • [36] Antitumor activity of Cetuximab in combination with Ixabepilone on triple negative breast cancer stem cells
    Tomonori Tanei
    Dong Soon Choi
    Angel A. Rodriguez
    Diana Hwang Liang
    Lacey Dobrolecki
    Madhumita Ghosh
    Melissa D. Landis
    Jenny C. Chang
    Breast Cancer Research, 18
  • [37] Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer
    Charan, Manish
    Das, Subhadip
    Mishra, Sanjay
    Chatterjee, Nabanita
    Varikuti, Sanjay
    Kaul, Kirti
    Misri, Swati
    Ahirwar, Dinesh K.
    Satoskar, Abhay R.
    Ganju, Ramesh K.
    CELL DEATH & DISEASE, 2020, 11 (09)
  • [38] Macrophage migration inhibitory factor inhibition as a novel therapeutic approach against triple-negative breast cancer
    Manish Charan
    Subhadip Das
    Sanjay Mishra
    Nabanita Chatterjee
    Sanjay Varikuti
    Kirti Kaul
    Swati Misri
    Dinesh K. Ahirwar
    Abhay R. Satoskar
    Ramesh K. Ganju
    Cell Death & Disease, 11
  • [39] Identification of lncRNAs as potential novel therapeutic targets in triple negative breast cancer
    O'Malley, Megan
    Rana, Zohaib
    Sarkar, Debina
    Chia, Jolyn
    Diermeier, Sarah
    CANCER RESEARCH, 2023, 83 (07)
  • [40] Cripto-1 as a novel therapeutic target for triple negative breast cancer
    Castro, Nadia P.
    Fedorova-Abrams, Natalie D.
    Merchant, Anand S.
    Rangel, Maria Cristina
    Nagaoka, Tadahiro
    Karasawa, Hideaki
    Klauzinska, Malgorzata
    Hewitt, Stephen M.
    Biswas, Kajal
    Sharan, Shyam K.
    Salomon, David S.
    ONCOTARGET, 2015, 6 (14) : 11910 - 11929
12345